Two in One: Use of Divalent Manganese Ions as Both Cross-Linking and MRI Contrast Agent for Intrathecal Injection of Hydrogel-Embedded Stem Cells
Authors:
- Lukasz KalkowskiLKLukasz Kalkowski
- Dominika GolubczykDGDominika Golubczyk
- Joanna KwiatkowskaJKJoanna Kwiatkowska
- Piotr HolakPHPiotr Holak
- Kamila MilewskaKMKamila Milewska
- Miroslaw JanowskiMiroslaw Janowski
- Joaquim Miguel OliveiraJoaquim Miguel Oliveira
- Piotr WalczakPiotr Walczak
- Izabela Malysz-CymborskaIMIzabela Malysz-Cymborska
Open Access
- 13 July 2021
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (7) , 1076
Abstract
Cell therapy is a promising tool for treating central nervous system (CNS) disorders; though, the translational efforts are plagued by ineffective delivery methods. Due to the large contact surface with CNS and relatively easy access, the intrathecal route of administration is attractive in extensive or global diseases such as stroke or amyotrophic lateral sclerosis (ALS). However, the precision and efficacy of this approach are still a challenge. Hydrogels were introduced to minimize cell sedimentation and improve cell viability. At the same time, contrast agents were integrated to allow image-guided injection. Here, we report using manganese ions (Mn2+) as a dual agent for cross-linking alginate-based hydrogels and magnetic resonance imaging (MRI). We performed in vitro studies to test the Mn2+ alginate hydrogel formulations for biocompatibility, injectability, MRI signal retention time, and effect on cell viability. The selected formulation was injected intrathecally into pigs under MRI control. The biocompatibility test showed a lack of immune response, and cells suspended in the hydrogel showed greater viability than monolayer culture. Moreover, Mn2+-labeled hydrogel produced a strong T1 MRI signal, which enabled MRI-guided procedure. We confirmed the utility of Mn2+ alginate hydrogel as a carrier for cells in large animals and a contrast agent at the same time.Keywords
Funding Information
- National Center for Research and Development (12/EuroNanoMed/2016)
This publication has 40 references indexed in Scilit:
- Astrocytes and microglia in neurodegenerative diseases: Lessons from human in vitro modelsProgress in Neurobiology, 2021
- Non-neuronal cells in amyotrophic lateral sclerosis — from pathogenesis to biomarkersNature Reviews Neurology, 2021
- Intra-arterial transplantation of stem cells in large animals as a minimally-invasive strategy for the treatment of disseminated neurodegenerationScientific Reports, 2021
- Clinical effects of intrathecal administration of expanded Wharton jelly mesenchymal stromal cells in patients with chronic complete spinal cord injury: a randomized controlled studyCytotherapy, 2021
- Generation of Neural Progenitor Cells From Canine Induced Pluripotent Stem Cells and Preliminary Safety Test in Dogs With Spontaneous Spinal Cord InjuriesFrontiers in Veterinary Science, 2020
- Intrathecal Injection of SIRT1-modified Human Mesenchymal Stem Cells Alleviates Neuropathic Pain in RatJournal of Molecular Neuroscience, 2020
- Mesenchymal stem cells injected into carotid artery to target focal brain injury home to perivascular spaceTheranostics, 2020
- Hydrogel-based scaffolds to support intrathecal stem cell transplantation as a gateway to the spinal cord: clinical needs, biomaterials, and imaging technologiesnpj Regenerative Medicine, 2018
- Overexpression of VLA-4 in glial-restricted precursors enhances their endothelial docking and induces diapedesis in a mouse stroke modelJournal of Cerebral Blood Flow & Metabolism, 2017
- Use of MR Cell Tracking to Evaluate Targeting of Glial Precursor Cells to Inflammatory Tissue by Exploiting the Very Late Antigen-4 Docking ReceptorRadiology, 2012